Skip to main content
. 2020 Dec 3;10(1):74–87. doi: 10.12997/jla.2021.10.1.74

Table 1. Baseline characteristics of study participants according to the HDL-C categories.

Characteristics HDL-C (mg/dL)
<30 30–39 40–49 50–59 60–69 70–79 80–89 ≥90
Men
No. 1,817 22,010 56,703 50,826 27,985 11,113 3,797 1,992
Age (yr) 59.4 ± 9.0 58.2 ± 8.6 57.7 ± 8.4 57.5 ± 8.3 57.8 ± 8.4 57.9 ± 8.4 58.1 ± 8.6 58.1 ± 8.3
BMI (kg/m2) 24.9 ± 2.8 24.9 ± 2.7 24.5 ± 2.7 24.1 ± 2.7 23.5 ± 2.8 23.1 ± 2.8 22.8 ± 2.8 22.4 ± 2.9
WC (cm) 87.1 ± 7.3 86.8 ± 7.0 85.6 ± 7.1 84.3 ± 7.3 83.0 ± 7.4 81.9 ± 7.5 81.3 ± 7.6 80.6 ± 7.9
Systolic BP (mmHg) 126.4 ± 14.6 126.3 ± 14.5 126.1 ± 14.5 126.4 ± 14.8 126.5 ± 15.1 126.8 ± 15.3 127.1 ± 15.0 127.8 ± 15.5
Diastolic BP (mmHg) 78.4 ± 9.9 78.6 ± 9.8 78.7 ± 9.7 78.9 ± 9.9 78.8 ± 9.9 79.1 ± 10.1 79.3 ± 9.9 79.5 ± 9.9
FBG (mg/dL) 107.7 ± 34.5 105.2 ± 29.8 103.9 ± 27.7 102.9 ± 26.1 102.1 ± 25.2 101.8 ± 25.2 102.8 ± 27.2 101.5 ± 27.1
Total cholesterol (mg/dL) 169.4 ± 38.5 183.9 ± 36.0 192.7 ± 35.4 198.8 ± 35.2 202.4 ± 35.4 207.0 ± 35.9 211.2 ± 37.1 215.9 ± 36.5
Triglyceride (mg/dL) 199 (137–287) 170 (120–240) 139 (100–197) 118 (85–167) 104 (75–146) 95 (68–133) 88 (64–126) 84 (60–119.5)
HDL-C (mg/dL) 25.2 ± 3.6 34.9 ± 2.6 43.7 ± 2.8 53.1 ± 2.8 62.8 ± 2.8 72.6 ± 2.8 82.7 ± 2.8 99.2 ± 12.8
LDL-C (mg/dL) 96.6 ± 37.3 109.8 ± 36.7 116.7 ± 35.1 118.2 ± 35.6 115.3 ± 37.1 112.0 ± 34.8 107.6 ± 35.1 97.3 ± 44.3
Current smoker 705 (38.8) 7,667 (34.8) 18,182 (32.1) 15,190 (29.9) 8,286 (29.6) 3,236 (29.1) 1,114 (29.3) 636 (31.9)
Alcohol (≥30 g/day) 105 (5.8) 1,259 (5.7) 4,116 (7.3) 4,605 (9.1) 3,010 (10.8) 1,337 (12.0) 536 (14.1) 283 (14.2)
Regular exercise 367 (20.2) 4,858 (22.1) 13,592 (24.0) 12,821 (25.2) 7,447 (26.6) 3,148 (28.3) 1,047 (27.6) 571 (28.7)
Household income (lower 25%) 138 (7.6) 1,392 (6.3) 3,459 (6.1) 2,914 (5.7) 1,771 (6.3) 718 (6.5) 251 (6.6) 140 (7.0)
Diabetes 456 (25.1) 4,503 (20.5) 9,534 (16.8) 7,297 (14.4) 3,611 (12.9) 1,300 (11.7) 468 (12.3) 226 (11.4)
Hypertension 908 (50.0) 10,204 (46.4) 24,404 (43.0) 20,866 (41.1) 11,053 (39.5) 4,398 (39.6) 1,497 (39.4) 785 (39.4)
Dyslipidemia 292 (16.1) 4,018 (18.3) 11,578 (20.4) 11,360 (22.4) 6,626 (23.7) 2,878 (25.9) 1,097 (28.9) 623 (31.3)
On lipid-lowering agent 242 (13.3) 3,008 (13.7) 7,627 (13.5) 6,697 (13.2) 3,577 (12.8) 1,441 (13.0) 514 (13.5) 244 (12.3)
Metabolic syndrome 1,483 (81.6) 16,936 (77.0) 29,628 (52.3) 21,817 (42.9) 10,805 (38.6) 3,997 (36.0) 1,354 (35.7) 686 (34.4)
Women
Number 878 10,976 38,416 51,713 37,373 17,729 6,946 3,413
Age (yr) 63.9 ± 9.7 62.4 ± 9.6 61.1 ± 9.2 59.8 ± 9.0 58.9 ± 8.9 58.0 ± 8.6 57.7 ± 8.4 57.5 ± 8.6
BMI (kg/m2) 24.7 ± 3.1 24.6 ± 3.0 24.4 ± 3.1 24.1 ± 3.0 23.7 ± 3.1 23.3 ± 3.0 23.0 ± 3.0 22.8 ± 3.0
WC (cm) 82.1 ± 7.9 81.3 ± 7.9 80.6 ± 8.0 79.4 ± 8.0 78.1 ± 8.1 77.0 ± 8.2 76.1 ± 8.2 75.6 ± 8.4
Systolic BP (mmHg) 126.4 ± 16.4 125.9 ± 15.9 125.3 ± 15.9 124.3 ± 15.8 123.4 ± 15.6 122.9 ± 16.0 122.6 ± 15.4 122.7 ± 15.5
Diastolic BP (mmHg) 77.2 ± 10.3 76.9 ± 9.9 76.7 ± 10.0 76.2 ± 10.0 75.9 ± 9.9 75.9 ± 10.1 75.8 ± 10.1 76.0 ± 10.2
FBG (mg/dL) 103.2 ± 34.3 101.7 ± 27.7 100.0 ± 24.5 98.3 ± 22.2 97.2 ± 20.9 96.3 ± 19.6 95.9 ± 19.8 96.5 ± 21.2
Total cholesterol (mg/dL) 176.8 ± 42.2 188.6 ± 37.9 198.7 ± 37.4 204.9 ± 37.1 210.3 ± 36.7 216.5 ± 37.0 221.4 ± 36.2 228.8 ± 39.0
Triglyceride (mg/dL) 182.5 (123–260) 162 (113–228) 134 (97–185) 111 (82–151) 97 (72–131) 86 (64–117) 80 (60–108) 77 (57–106)
HDL-C (mg/dL) 25.1 ± 4.0 35.0 ± 2.5 44.0 ± 2.8 53.4 ± 2.8 63.0 ± 2.8 72.8 ± 2.8 82.6 ± 2.8 97.9 ± 10.9
LDL-C(mg/dL) 108.6 ± 43.5 116.9 ± 37.7 124.3 ± 36.1 126.4 ± 37.0 125.5 ± 36.6 123.9 ± 35.5 120.4 ± 34.6 113.4 ± 42.6
Current smoker 22 (2.5) 248 (2.3) 700 (1.8) 854 (1.7) 585 (1.6) 260 (1.5) 97 (1.4) 69 (2.0)
Alcohol (≥30 g/day) 1 (0.1) 14 (0.1) 47 (0.1) 115 (0.2) 107 (0.3) 65 (0.4) 38 (0.6) 34 (1.0)
Regular exercise 133 (15.2) 1,701 (15.5) 6,629 (17.3) 9,532 (18.4) 7,293 (19.5) 3,690 (20.8) 1,462 (21.1) 765 (22.4)
Household income (lower 25%) 99 (11.3) 1,149 (10.5) 3,974 (10.3) 5,225 (10.1) 3,879 (10.4) 1,818 (10.3) 770 (11.1) 397 (11.6)
Diabetes 191 (21.8) 2,031 (18.5) 5,532 (14.4) 5,786 (11.2) 3,383 (9.1) 1,297 (7.3) 463 (6.7) 240 (7.0)
Hypertension 483 (55.0) 5,719 (52.1) 17,920 (46.7) 21,473 (41.5) 13,833 (37.0) 6,082 (34.3) 2,286 (32.9) 1,113 (32.6)
Dyslipidemia 192 (21.9) 2,721 (24.8) 10,817 (28.2) 15,890 (30.7) 12,187 (32.6) 6,339 (35.8) 2,724 (39.2) 1,539 (45.1)
On lipid-lowering agent 155 (17.7) 2,134 (19.4) 7,730 (20.1) 10,395 (20.1) 7,401 (19.8) 3,477 (19.6) 1,432 (20.6) 741 (21.7)
Metabolic syndrome 707 (80.5) 8,326 (75.9) 26,733 (69.6) 26,280 (50.8) 16,127 (43.2) 7,052 (39.8) 2,706 (39.0) 1,398 (41.0)

Values are mean±standard deviation, %, or median (interquartile range).

HDL-C, high-density lipoprotein cholesterol; BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; LDL-C, low-density lipoprotein cholesterol; BP, blood pressure.